BiotechTube
Home/Sparian Biosciences/Jeff Reich, M.D.
JR

Jeff Reich, M.D.

Chief Executive Officer and Co-founder

Sparian Biosciences

Therapeutic Areas

Central Nervous System (CNS)PainSubstance Use DisordersOpioid Use DisorderStimulant Use Disorder

Sparian Biosciences Pipeline

DrugIndicationPhase
SBS1000Pain (non-opioid analgesic)Phase 1
SBS-226Opioid Use Disorder (OUD) / Opioid Withdrawal Syndrome (OWS)Preclinical
SBS-518Stimulant Use Disorder (StUD)Preclinical